Free Trial

Marinus Pharmaceuticals (MRNS) SEC Filings & 10K Form

Marinus Pharmaceuticals logo
$0.55 0.00 (-0.16%)
As of 02/11/2025

Recent Marinus Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/14/2025
3:30 PM
Marinus Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
Form SCHEDULE 13G/A
02/13/2025
11:15 PM
Marinus Pharmaceuticals (Filer)
Form EFFECT
02/13/2025
11:15 PM
Marinus Pharmaceuticals (Filer)
Form EFFECT
02/13/2025
11:15 PM
Marinus Pharmaceuticals (Filer)
Form EFFECT
02/12/2025
5:40 PM
Marinus Pharmaceuticals (Subject)
Sofinnova Investments, Inc. (Filed by)
Form SCHEDULE 13G/A
02/11/2025
7:45 PM
Marinus Pharmaceuticals (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SCHEDULE 13G
02/11/2025
7:20 PM
Marinus Pharmaceuticals (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SCHEDULE 13G/A
02/11/2025
10:08 AM
FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/11/2025
7:53 AM
Marinus Pharmaceuticals (Filer)
Form S-8 POS
02/11/2025
7:53 AM
Marinus Pharmaceuticals (Filer)
Form S-8 POS
02/11/2025
7:54 AM
Marinus Pharmaceuticals (Filer)
Form S-8 POS
02/11/2025
7:54 AM
Marinus Pharmaceuticals (Filer)
Form S-8 POS
02/11/2025
7:54 AM
Marinus Pharmaceuticals (Filer)
Form S-8 POS
02/11/2025
7:54 AM
Marinus Pharmaceuticals (Filer)
Form S-8 POS
02/11/2025
7:55 AM
Marinus Pharmaceuticals (Filer)
Form S-8 POS
02/11/2025
7:55 AM
Marinus Pharmaceuticals (Filer)
Form S-8 POS
02/11/2025
8:05 AM
Marinus Pharmaceuticals (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
02/11/2025
8:10 AM
Marinus Pharmaceuticals (Issuer)
Silverstein Christine Berni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
8:11 AM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
8:12 AM
Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
8:13 AM
Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
8:14 AM
Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
8:16 AM
MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
8:17 AM
Johnson Marvin (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
8:18 AM
Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
8:19 AM
Fischer Seth H. Z. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
8:19 AM
Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
7:49 AM
Marinus Pharmaceuticals (Filer)
Form POS AM
02/11/2025
7:41 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
7:48 AM
Marinus Pharmaceuticals (Filer)
Form POS AM
02/11/2025
7:49 AM
Marinus Pharmaceuticals (Filer)
Form POS AM
02/07/2025
6:01 AM
Immedica Pharma AB (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC TO-T/A
02/07/2025
6:10 AM
Marinus Pharmaceuticals (Subject)
Form SC 14D9/A
02/04/2025
1:13 PM
Marinus Pharmaceuticals (Subject)
MORGAN STANLEY (Filed by)
Form SCHEDULE 13G
01/31/2025
11:14 AM
Marinus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/29/2025
4:17 PM
Immedica Pharma AB (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC TO-T/A
01/29/2025
3:44 PM
Marinus Pharmaceuticals (Subject)
Form SC 14D9/A
01/23/2025
3:16 PM
Johnson Marvin (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:17 PM
Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:41 PM
Immedica Pharma AB (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC TO-T
01/07/2025
6:15 PM
Beryl Capital Management LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SCHEDULE 13G
Secret financial plot unfolding in Washington DC… [DEVELOPING] (Ad)

What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. You see, I’ve recently uncovered a secret financial plot unfolding in Washington DC…

So please take a moment to watch it now.
01/02/2025
2:25 PM
Immedica Pharma AB (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC TO-C
12/30/2024
6:11 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
6:11 AM
Marinus Pharmaceuticals (Subject)
Form SC14D9C
12/30/2024
6:00 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
3:02 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
2:18 PM
Marinus Pharmaceuticals (Subject)
Nochur Sara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
9:35 AM
Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
11/15/2024
7:00 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
5:39 PM
Marinus Pharmaceuticals (Subject)
Sofinnova Investments, Inc. (Filed by)
Form SC 13G
11/14/2024
2:04 PM
Cormorant Asset Management, LP (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
11/14/2024
11:24 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
11/14/2024
8:34 AM
Avoro Capital Advisors LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
11/12/2024
8:55 AM
JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
11/01/2024
7:30 PM
Marinus Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
Form SC 13G
10/31/2024
12:05 PM
FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
10/24/2024
7:05 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
6:57 AM
Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
6:56 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
7:15 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:00 AM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
6:09 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
3:27 PM
Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:27 PM
Marinus Pharmaceuticals (Issuer)
Silverstein Christine Berni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:20 PM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:21 PM
Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:21 PM
Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:21 PM
MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:22 PM
Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:23 PM
Austin Charles (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:23 PM
Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:01 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
3:55 PM
Marinus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/24/2024
5:35 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
6:05 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
6:05 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
6:07 AM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
4:51 PM
CITADEL ADVISORS LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G
04/19/2024
5:04 AM
Marinus Pharmaceuticals (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
04/15/2024
6:32 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
7:00 AM
Marinus Pharmaceuticals (Filer)
Form DEF 14A
04/04/2024
7:02 AM
Marinus Pharmaceuticals (Filer)
Form DEFA14A
03/27/2024
10:55 AM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MRNS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners